Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J M Ross

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Endocrinology|November 11, 2006
Membrane reinsertion of a myristoyl-peptidyl anchored extracellular domain growth hormone receptorC E Bowles, I Wilkinson, R A G Smith, et al.
European Journal of Endocrinology|February 27, 2008
Women gain weight and fat mass despite lipectomy at abdominoplasty and breast reductionA S Rinomhota, D U S Bulugahapitiya, S J French, et al.
Endocrinology, Diabetes & Metabolism Case Reports|July 20, 2017
Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegalyW K M G Amarawardena, K D Liyanarachchi, J D C Newell-Price, et al.
European Journal of Endocrinology|January 10, 2004
Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal menR J M Ross, A Jabbar, T H Jones, et al.
International Journal of Andrology|January 5, 2006
Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadismZ Merza, A Blumsohn, P M Mah, et al.
The Journal of Endocrinology|February 8, 2006
A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signalingM Maamra, A Milward, H Zarkesh Esfahani, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2K C Leung, N Doyle, M Ballesteros, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional studyD M Greenfield, S J Walters, R E Coleman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transductionA Milward, L Metherell, M Maamra, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 30, 2002
Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunctionL Patel, C D Cooper, N D Quinton, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Endocrinology|November 11, 2006
Membrane reinsertion of a myristoyl-peptidyl anchored extracellular domain growth hormone receptorC E Bowles, I Wilkinson, R A G Smith, et al.
European Journal of Endocrinology|February 27, 2008
Women gain weight and fat mass despite lipectomy at abdominoplasty and breast reductionA S Rinomhota, D U S Bulugahapitiya, S J French, et al.
Endocrinology, Diabetes & Metabolism Case Reports|July 20, 2017
Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegalyW K M G Amarawardena, K D Liyanarachchi, J D C Newell-Price, et al.
European Journal of Endocrinology|January 10, 2004
Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal menR J M Ross, A Jabbar, T H Jones, et al.
International Journal of Andrology|January 5, 2006
Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadismZ Merza, A Blumsohn, P M Mah, et al.
The Journal of Endocrinology|February 8, 2006
A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signalingM Maamra, A Milward, H Zarkesh Esfahani, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2K C Leung, N Doyle, M Ballesteros, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional studyD M Greenfield, S J Walters, R E Coleman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transductionA Milward, L Metherell, M Maamra, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 30, 2002
Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunctionL Patel, C D Cooper, N D Quinton, et al.
Pageof 2